Tom Brady's Relationship With Charity Examined NCAA Lifts Ban On North Carolina Hosting Events Monfort: Coors Field Needs More Upkeep NCAA, ACC Mulling Returning Events To N.C. Rockies Staying At Coors Field Through '47 Miami Mayor Comments On Miami Open's Future Stephen Ross Interested In Miami Open NCAA Issues Final Warning To N.C. Over HB2 Hawks Bring Back Sports In Society Symposium Red Sox P David Price Addresses Athlete Activism
Upcoming Conferences and Events
May 31 - Jun 1
FDA TO LAY OFF ANDRO; DENVER WRITER CHASTISED FOR SNOOPING
Published August 28, 1998
The FDA "said it has no reason to step up scrutiny" of androstenedione after all the attention the product has received this week, according to Kristin Reed of BLOOMBERG NEWS. FDA spokesperson Ruth Welch: "The FDA is not aware that this product used in the marketplace presents a hazard to the public health" (BLOOMBERG NEWS, 8/28). Meanwhile, the ATP Tour banned androstenedione and will inform players of the move before the U.S. Open on Monday. The ruling "adds to the ban instituted" by the ITF (N.Y. TIMES, 8/28). CAUGHT SNOOPING: The BBWAA has "suspended" Denver Post columnist Mark Kiszla until the end of the regular season after he was "seen picking up" a bottle of Andro-6 from Rockies LF Dante Bichette's locker during batting practice Wednesday, "a time when the clubhouse generally is closed to all media." Kiszla later addressed the team in a clubhouse meeting on Thursday. The Rockies also revoked Kiszla's credentials (Tony Jackson, ROCKY MOUNTAIN NEWS, 8/28).